thalidomide has been researched along with Granuloma Annulare in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Granuloma Annulare: Benign granulomatous disease of unknown etiology characterized by a ring of localized or disseminated papules or nodules on the skin and palisading histiocytes surrounding necrobiotic tissue resulting from altered collagen structures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We present a 75-year-old Caucasian man with a violaceous ring-like firm, papular eruption, localized on the dorsal aspect of both hands, with histological features of GA, which subsequently resolved with the discontinuation of thalidomide he had started 1 month earlier for the treatment of a multiple myeloma." | 7.80 | Thalidomide-induced granuloma annulare. ( Atzori, L; Caddori, A; Ferreli, C; Manunza, F; Pau, M, 2014) |
| " We present a 75-year-old Caucasian man with a violaceous ring-like firm, papular eruption, localized on the dorsal aspect of both hands, with histological features of GA, which subsequently resolved with the discontinuation of thalidomide he had started 1 month earlier for the treatment of a multiple myeloma." | 3.80 | Thalidomide-induced granuloma annulare. ( Atzori, L; Caddori, A; Ferreli, C; Manunza, F; Pau, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, TP | 1 |
| Duvic, M | 1 |
| Hansel, K | 1 |
| Biondi, F | 1 |
| Bianchi, L | 1 |
| Tramontana, M | 1 |
| Marietti, R | 1 |
| Stingeni, L | 1 |
| Ferreli, C | 1 |
| Atzori, L | 1 |
| Manunza, F | 1 |
| Pau, M | 1 |
| Caddori, A | 1 |
2 reviews available for thalidomide and Granuloma Annulare
| Article | Year |
|---|---|
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options.
Topics: Anti-Infective Agents; Antimalarials; Biological Therapy; Comorbidity; Dermatologic Agents; Diabetes | 2022 |
Generalized granuloma annulare successfully treated with apremilast: report of two cases and literature review.
Topics: Adult; Aged; Female; Granuloma Annulare; Humans; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; | 2021 |
1 other study available for thalidomide and Granuloma Annulare
| Article | Year |
|---|---|
Thalidomide-induced granuloma annulare.
Topics: Aged; Granuloma Annulare; Hand; Humans; Immunosuppressive Agents; Male; Multiple Myeloma; Thalidomid | 2014 |